BioSpace News Archive

MyMD Pharmaceuticals, Inc.® (Nasdaq: MYMD) (“MyMD” or “the Company”), announced today that it has entered into a material transfer agreement (MTA) with Bascom Palmer Eye Institute of Miami, Florida to collaborate on a pre-clinical study using MYMD-1® as a potential treatment for traumatic optic neuropathy (TON).

The global Three-Dimensional (3D) imaging market size is expected to reach USD 104.19 Billion in 2030 and register a revenue CAGR of 20.9% over the forecast period, according to latest report by Reports and Data. Increasing investments by prominent market players is a key factor driving 3D imaging market revenue growth.

SYNAPS Dx, a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer’s disease, is pleased to announce that physicians in the Dallas/Fort Worth areas will be among the first in the country to offer area residents access to DISCERN™, a minimally invasive diagnostic test.

The global medical foods market size is expected to reach USD 33.85 Billion in 2030 and register a revenue CAGR of 5.4% over the forecast period, according to latest report by Reports and Data.

Selux Diagnostics, Inc. announced that it has been awarded an additional $8.0 million from the Biomedical Advanced Research and Development Authority, a division of the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response.

The global orthopedics diagnostic devices market size reached USD 11,024.00 Million in 2021 and is expected to register a revenue CAGR of 3.9% during the forecast period, according to latest analysis by Emergen Research

Halberd Corporation (OTC Pink: HALB) This past quarter has witnessed some very significant technical and organizational achievements by the Halberd team.

VisionHealth and Boehringer Ingelheim will cooperate on the Kata® app for therapy support in asthma and chronic obstructive pulmonary disease (COPD).

EpicentRx Inc. (“EpicentRx”), is pleased to announce that it has been awarded a $500,000 Therapeutics RFP grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF), to study potential neuroprotective effects of its lead small molecule, RRx-001 in Parkinson’s disease (PD).

Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today signed an exclusive distribution agreement in Greece for the CompuFlo ® Epidural System with F&M Feed, a leading provider of medical equipment, devices and consumables.